Comments
Novartis heart failure drug cuts death by 37 percent: study
07.11.2012. | LOS ANGELES (Reuters) - An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a late stage clinical trial presented on Tuesday....
